These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19475694)

  • 1. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
    Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J
    Hepatology; 2009 Jun; 49(6):1926-34. PubMed ID: 19475694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.
    Ye Z; Wang S; Yang Z; He M; Zhang S; Zhang W; Wen J; Li Q; Huang Y; Wang X; Lu B; Zhang Z; Su Q; Hu R
    Mol Biol Rep; 2014 Mar; 41(3):1317-23. PubMed ID: 24390241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
    Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis.
    Li Y; Liu L; Wang B; Wang J; Chen D
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):332-8. PubMed ID: 24172912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.
    Choi KM; Kim TN; Yoo HJ; Lee KW; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):569-74. PubMed ID: 18710473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.
    Park CG; Choi KM
    Clin Exp Hypertens; 2014; 36(7):478-83. PubMed ID: 24491219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
    Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults".
    Kanaka-Gantenbein C; Margeli A; Pervanidou P; Sakka S; Mastorakos G; Chrousos GP; Papassotiriou I
    Clin Chem; 2008 Jul; 54(7):1176-82. PubMed ID: 18487287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.
    van der Poorten D; Milner KL; Hui J; Hodge A; Trenell MI; Kench JG; London R; Peduto T; Chisholm DJ; George J
    Hepatology; 2008 Aug; 48(2):449-57. PubMed ID: 18627003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
    Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
    Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
    Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytokines mark insulin sensitivity in euthyroid Hashimoto's patients.
    Solini A; Dardano A; Santini E; Polini A; Monzani F
    Acta Diabetol; 2013 Feb; 50(1):73-80. PubMed ID: 22639339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue.
    Mak LY; Lee CH; Cheung KS; Wong DK; Liu F; Hui RW; Fung J; Xu A; Lam KS; Yuen MF; Seto WK
    Liver Int; 2019 Jul; 39(7):1217-1225. PubMed ID: 30912255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD).
    Sommer G; Ziegelmeier M; Bachmann A; Kralisch S; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):901-5. PubMed ID: 18419784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.